
The response rate has been frequently used as the primary zzso of phase II cancer clinical zzso It may not be an appropriate zzso when a new treatment is not expected to produce any zzso zzso When a large database for a historical control is available, the direct comparison of survival zzso between a new treatment and the historical control may be made in phase II cancer clinical zzso In this paper, a zzso zzso test is introduced for the design and analysis of phase II cancer clinical trials with zzso zzso Corrections to the zzso zzso test are also derived based on the zzso zzso zzso showed that the original zzso zzso test may be preferred if strictly controlling for type I error is important or when the sample size of a phase II trial is as large as 50, and a corrected zzso zzso test is used if the sample size of a phase II trial is zzso A data set from a clinical trial conducted by the zzso Clinical Trials Group is used to illustrate the proposed zzso 

